Table of Content
- Vol.30, No.1, 2022
- Vol.30, No.2, 2022
- Vol.30, No.3, 2022
- Vol.30, No.4, 2022
- Vol.30, No.5, 2022
- Vol.30, No.6, 2022
- Vol.29, No.1, 2021
- Vol.29, No.2, 2021
- Vol.29, No.3, 2021
- Vol.29, No.4, 2021
- Vol.29, No.5, 2021
- Vol.29, No.6, 2021
- Vol.28, No.1, 2020
- Vol.28, No.2, 2020
- Vol.28, No.3, 2020
- Vol.28, No.4, 2020
- Vol.28, No.5, 2020
- Vol.28, No.6, 2020
- Vol.28, No.7-8, 2020
- Vol.28, No.9, 2020
- Vol.27, No.1, 2019
- Vol.27, No.2, 2019
- Vol.27, No.3, 2019
- Vol.27, No.4, 2019
- Vol.27, No.5, 2019
- Vol.27, No.6, 2019
- Vol.27, No.7, 2019
- Vol.27, No.8, 2019
- Vol.27, No.9, 2019
Editors-in-Chief
-
Edward Chu
Albert Einstein College of Medicine, USA
Interests: cancer pharmacology and drug development
-
Enrico Mini
University of Florence Florence, ITALY
Interests: the mechanisms of tumor drug resistance, in particular to antimetabolites and metal-based drugs, cancer pharmacogenomics and pharmacogenetics, and controlled clinical trials in gastrointestinal cancers
-
Kazuo Umezawa
Aichi Medical University, JAPAN
Interests: CPR, resuscitation, critical care medicine, intensive care medicine, hypothermia, emergency management, emergency treatment, sepsis, ventilation, ICU
Editorial Board Members
-
Jinhua Wang
National Center for Pharmaceutical Screening, Institute of Materia Medica, CHINA
Interests: the mechanism and drug targets of cancers
-
Makoto Kawatani
RIKEN Center for Sustainable Resource Science (CSRS), JAPAN
Interests: Chemical biology, Drug development and Cancer research
-
Nocentini Giuseppe
University of Perugia, ITALY
Interests: Pharmacology, Immunotoxicology and Pharmacoimmunology
-
Hiroyuki Osada
RIKEN Center for Sustainable Resource Science (CSRS), JAPAN
Interests: chemical biology research
-
Wunchana Seubwai
Khon Kaen University, THAILAND
Interests: cancer biology, cell signaling,cell culture, immunohistochemistry, apoptosis, cell proliferation, biochemistry, cancer cell biology, molecular cell biology, gene expression
-
Ryouichi Horie
Kitasato University, JAPAN
Interests: molecular hematology, medical sciences
-
David A. Gewirtz
Virginia Commonwealth University, USA
Interests: Autophagy, Cell biology, Programmed cell death, Apoptosis and Senescence
-
Aamir Ahmad
University of Alabama at Birmingham, USA
Interests: Cancer Metastasis, Drug Resistance, miRNA and Cancer Health Disparity
-
Isao Momose
Institute of Microbial Chemistry, JAPAN
Interests: Bioorganic chemistry; Applied biochemistry and Applied microbiology
-
Yohko Yamazaki
Institute of Microbial Chemistry, JAPAN
Interests: Androgen receptors, prostate cancer, anticancer drugs and phospholipid remodeling
-
Luca Maria Munaron
University of Torino, ITALY
Interests: tumor-derivedendothelial cells, drugdelivering against tumor vascularization and Bone vascularization and biomaterials
-
Petar Ozretić
Laboratory for Hereditary Cancer, Ruđer Bošković Institute (RBI), CROATIA
Interests: Cancer genetics, epigenetics, Bioinformatics, Biostatistics and Molecular oncology
-
Sanjay Gupta
Case Western Reserve University, USA
Interests: cancer biomarkers, cancer therapeutics and drug repurposing and cancer stem cells research
-
Hong Shen
Xiangya Hospital, Central South University, CHINA
Interests: Tumor microenvironment, immunotherapy, Tumor metabolism, Epigenetic therapy, Single-cell sequencing, Cell proliferation, Tumor metastasis
-
Jianxun Jim Song
Texas A&M University Health Science Center, USA
Interests: T cell biology, Immunotherapy, Stem cells, Cancer, Autoimmunity, Cell metabolism, Signal transduction
-
Ning Wei
Montefiore Einstein Cancer Center, USA
Interests: Cancer Pharmacology and Drug Discovery
-
Tao Liu
Lowy Cancer Research Centre, AUSTRALIA
Interests: Oncology and Carcinogenesis, Cancer Cell Biology, Cancer Genetics, Cancer Therapy
-
Jinhui Liu
The First Affiliated Hospital of Nanjing Medical University, CHINA
Interests: Biomarker, Prognostic Model, Non-Coding RNA, Machine Learning, Bioinformatics, Immunology
-
Mohammad Oves
King Abdulaziz University, SAUDI ARABIA
Interests: Multidrug resistance, Antimicrobial agents and
Nanomaterials bio-fabrication, Biofilm, Chromium reduction and Phosphate solubilization microbe
-
Mohammad Rahimi-Gorji
Ghent University, BELGIUM
Interests: Cancer and tumor modeling, Drug delivery, Intraperitoneal chemotherapy, CFD simulation of drug delivery, Biomedical modeling
-
Xu Dong Zhang
University of Newcastle, AUSTRALIA
Interests: Melanoma, Pancreatic, Colorectal & Rare Cancers
-
Chunlin Ou
Xiangya Hospital, Central South University, CHINA
Interests: The regulatory mechanism of non-coding RNAs in cancers, Clinical application of mRNA vaccine in cancers.
-
Yingying Lin
Shanghai Jiaotong University, CHINA
Interests: Tumor microenvironment, Protease, Glioma
-
Stefania Nobili
University of Florence, ITALY
Interests: Pharmacology, Applied pharmacology
-
Hardeep Singh Tuli
Maharishi Markandeshwar University, INDIA
Interests: Cordyceps, Nanoparticles, Cancer Biology, Microbial Biotechnology, Cell Cycle, Therapeutics
-
Ciro Isidoro
Università del Piemonte Orientale, ITALY
Interests: Cancer Biology, Autophagy, Cell Death, Cell Biology, Cancer Research, Apoptosis, Cell Proliferation
-
Antonio Ruggiero
Fondazione Policlinico Universitario Gemelli IRCCS, ITALY
Interests: Pediatric clinical trials, Clinical pharmacology of antineoplastic drugs, Pain therapy and Pediatric drugs
-
Francesca De Felice
Sapienza University of Rome, ITALY
Interests: Gastrointestinal cancers, Head and neck cancers, Gynecological cancers, Machine learning data analysis, Survival analysis
-
William CHO
Queen Elizabeth Hospital, Hong Kong
Interests: Molecular biology, Proteomics, Genomics, Immunology, Bioinformatics, Next-generation sequencing
-
Ammad Ahmad Farooqi
Institute of Biomedical and Genetic Engineering, PAKISTAN
Interests: Cancer Genetics and Therapeutics, Targeting of Oncogenic Signaling Pathways using Natural products, Restoration of Apoptotic Pathway in resistant Cancers
-
Bahil Ghanim
Karl Landsteiner University of Health Sciences, AUSTRIA
Interests: Biomarkers, thoracic surgery, lung cancer, mesothelioma, minimal invasive surgery and solitary fibrous tumor of the lung
-
Yong Teng
Emory University School of Medicine, USA
Interests: Tumor microenvironment, tumor metabolism, and metastasis with an emphasis on molecular determinants
-
Marina Kriajevska
University of Leicester, UK
Interests: Cell signaling, bladder cancer
-
Tao Li
Qilu Hospital, Shandong University, CHINA
Interests: The biology and treatment of Hepatobiliary tumors
Early Career Editorial Board Member
-
Romeo Patini
Catholic university of Sacred Heart Rome, ITALY
Interests: Molecular biology, Biological fluids proteomics
-
Chavda Vivek Prakash Bhai
L.M. College of Pharmacy, INDIA
Interests: Complex injectable, Biologics, Immunotherapy and Vaccine
Editorial Advisory Board
-
L. J. Appleman
University of Pittsburgh, USA
Interests: tumor immunology, clinical trial of an autologous dendritic cell vaccine, cancer immunotherapy
-
N. Bahary
University of Pittsburgh, USA
Interests: oncologists diagnose, cancer surgeons, or surgical oncologists, remove tumors, while medical oncologists treat cancers with chemotherapy, gastrointestinal cancer
-
J. R. Bertino
Rutgers Cancer Institute of New Jersey, USA
Interests: cancer biology, lymphomas, antimetabolites
-
J. H. Beumer
Hillman Cancer Center, USA
Interests: pharmacology, toxicology
-
M. Boyiadzis
University of Pittsburgh, USA
Interests: internal medicine, hematology/oncology, medical oncology
-
Y.-C. Cheng
Yale University School of Medicine, USA
Interests: pharmacology, antiviral drugs against HBV, HIV, EBV, and HCV, as well as the discovery of antivirals with unique mode of action against those viruses.
-
M. S. Copur
University of Nebraska, USA
Interests: medical oncology, hematology
-
A. Krishnamurthy
University of Pittsburgh, USA
Interests: diagnosis and multidisciplinary management of gastrointestinal (GI) cancers
-
Y. Li
Sorrento Therapeutics, USA
Interests: tumor immunology, molecular biology, medical genetics and clinical medicine
-
M. Rudek
Johns Hopkins University, USA
Interests: clinical pharmacology of anticancer agents; early phase drug development; drug tolerability in cancer patients with HIV/AIDS; drug tolerability in cancer patients with organ dysfunction; blood-brain barrier penetration of drugs.
-
J. C. Schmitz
University of Pittsburgh, USA
Interests: pharmacodynamic, the mechanism(s) of action of quassinoids on colorectal cancer cells and tumors
-
L. Zhang
University of Pittsburgh, USA
Interests: pharmacology and chemical Biology
-
A. H. Calvert
University of Newcastle upon Tyne, UK
Interests: tumor biology
-
A. Di Paolo
University of Pisa, ITALY
Interests: pharmacology, clinical pharmacokinetics and PK/PD of antineoplastic and antiinfective drugs
-
D. Longley
Queen’s University, UK
Interests: apoptosis proteins, birinapant, poptosis
-
J. Robert
Université de Bordeaux, FRANCE
Interests: pharmacocinétique, métabolisme et résistance, pharmacologie cellulaire et moléculaire, pharmacogénétique
-
J. H. M. Schellens
Netherlands Cancer Institute, the Netherlands
Interests: clinical pharmacology
-
P. Workman
CRC Center for Cancer Therapeutics, UK
Interests: drug discovery, molecular pharmacology and chemical biology approaches
-
A. Deguchi
Tokyo Women’s Medical University, JAPAN
Interests: pharmacology, cancer research
-
X. Ding
Nanjing Medical University, CHINA
Interests: digestive diseases
-
S. Gantsev
Bashkirian State Medical University, RUSSIAN
Interests: pharmacology
-
Y. Horiguchi
Tokyo Medical University, JAPAN
Interests: biomaterials and bioengineering
-
M. Imoto
Keio University, JAPAN
Interests: nanotechnology, materials, chemical biology
-
H. Kakeya
Kyoto University, JAPAN
Interests: chemical biology
-
M. Kawatani
RIKEN, JAPAN
Interests: interdisciplinary science & engineering, biological sciences
-
E. Kikuchi
Keio University, JAPAN
Interests: neuropsychiatry
-
K. P. Kim
University of Ulsan College of Medicine, KOREA
Interests: pre-medicine, clinical pharmacology
-
T. W. Kim
University of Ulsan College of Medicine, KOREA
Interests: medicine
-
Y. Lin
Aichi Medical University, JAPAN
Interests: pancreatic cancer, gastric cancer, epidemiologic studies, esophageal cancer
-
J. Neuzil
Griffith University, Gold Coast Campus, AUSTRALIA
Interests: medical microbiology, oncology and carcinogenesis
-
O. Ohno
Kogakuin University, JAPAN
Interests: immunology
-
T. Ohsugi
Rakuno Gakuen University, JAPAN
Interests: genetically modified mice, MNVmouse norovirusspecific pathogen-freemicrobiological monitoring HTLV-1 animal modeltaxTransgenic miceATLL
-
M. Oya
Keio University, JAPAN
Interests: urology
-
M. Ozaki
Hokkaido University, JAPAN
Interests: biomedical imaging, oxidative stress, non-alcoholic fatty liver disease
-
Y. Sasazawa
Juntendo University, JAPAN
Interests: proteomics and biomolecular science
-
K. Sidthipong
Mahidol University, THAILAND
Interests: biology, chemistry, bioorganic & medicinal chemistry letters
-
S. Simizu
Keio University, JAPAN
Interests: cancer, molecular target therapy, inflammation, chemical biology
-
M. Takeiri
Ivy Cosmetics, JAPAN
Interests: osteoclasts
-
E. Tashiro
Showa Pharmaceutical University, JAPAN
Interests: nature chemical biology
-
T. Ueno
Tsukuba University, JAPAN
Interests: materials science
-
M. Yamamoto
Waseda University, JAPAN
Interests: infrared, FTIR analysis, infrared spectrophotom